PENGARUH KEPATUHAN MINUM OBAT PASIEN TB PARU DI PUSKESMAS PACCERAKKANG TAHUN 2022

  • Sukirawati Sukirawati AKADEMI FARMASI YAMASI MAKASSAR

Abstract

 In Indonesia, pulmonary TB is the number one killer disease among infectious diseases and ranks third in the category of the ten highest killer diseases in Indonesia. The purpose of this study was to determine the effect of medication adherence in pulmonary TB patients at the Paccerakg Public Health Center in 2022. This study included an observational descriptive study. This descriptive study was conducted on a group of objects where the samples in this study were patients taking pulmonary TB drugs. The results of this study can be concluded that as many as 66% of patients taking pulmonary TB drugs at the Paccerakg Health Center complied with taking the drug.

References

Kepatuhan minum obat
TB paru
Puskesmas
Published
2022-07-31